Blood Journal/X
Jun 7, 2025, 10:28
IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
The Blood Journal featured a post highlighting the published article on X:
“Hallmarks of IL-10 deficiency predict R-CHOP response but reflect poor antitumor immunity in preclinical models and patients with DLBCL.”
Title: IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy
Authors: Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, Marién Pascual, Enrique Goñi, Iñigo Clemente-Larramendi, Sandra Morales-Sánchez, María A. Burrell, Oscar Blanco, Adrián Arnaiz-Leché, Blanca S. Berrozpe, Maria Amann, Christian Klein, Pablo Umaña, Miguel Canales, José Ángel Martínez-Climent, Juan J. Lasarte, Pablo Sarobe, Francisco J. Novo, Sergio Roa
Find more posts on Hemostasis Today.
-
Aug 25, 2026, 11:18Caitlin Raymond: Your Blood Type Doesn’t Define Your Personality
-
Aug 25, 2026, 11:18N. Mariana S. Vasquez: USMLE Key Differences – Marfan Syndrome vs. Homocystinuria
-
Aug 25, 2026, 11:16Miguel Bronchud: Making Monoclonal Antibodies Safer in Pregnancy
-
Aug 25, 2026, 11:14Natalie Arnold: Germany Recognizes Low-Dose Colchicine in CVD Prevention
-
Aug 25, 2026, 11:08William Aird: Iron Deficiency vs. Inflammation – Look at the Minivans
-
Aug 25, 2026, 11:04Jayr Schmidt Filho: Real-World Brazilian Data Reveal Inequalities in MDS Care
-
Aug 25, 2026, 07:28Manuel Monreal: VTE and Severe Renal Insufficiency – What Does RIETE Tell Us?
-
Aug 25, 2026, 07:26Tom B.: Platelet Transfusion as a Potential Mitochondrial Therapy for Sepsis
-
Aug 25, 2026, 07:20Scott McInnes: Giving Blood When the Need Is Greater Than Ever